Rchr
J-GLOBAL ID：201601013410720955
Update date: Apr. 26, 2024
Li Xia
Li Xia
Affiliation and department：
Research field (2)：
Biomaterials
, Nanobioscience
Research theme for competitive and other funds (3)：
- 2023 - 2026 ナノコンプレックスによる個別化複合がん免疫療法の開発
- 2022 - 2024 低温自己組織化によるがん治療ナノワクチンの開発
- 2009 - 2011 生物学的シグナル分子を担持した癌免疫療法用複合メソポーラスアジュバンド
Papers (74)：
-
Xia Li, Shinya Hattori, Mitsuhiro Ebara, Naoto Shirahata, Nobutaka Hanagata. A facile approach to preparing personalized cancer vaccines using iron-based metal organic framework. Frontiers in Immunology. 2024
-
Xia Li, Tomohiko Yamazaki, Mitsuhiro Ebara, Naoto Shirahata, Nobutaka Hanagata. Rational design of adjuvants boosts cancer vaccines. Progress in Molecular Biology and Translational Science. 2024
-
Xia Li, Tomohiko Yamazaki, Mitsuhiro Ebara, Naoto Shirahata, Nobutaka Hanagata. Nanoengineered coordination polymers boost cancer immunotherapy. Materials Today. 2023
-
Cijun Shuai, Desheng Li, Xiong Yao, Xia Li, Chengde Gao. Additive Manufacturing of Promising Heterostructure for Biomedical Applications. International Journal of Extreme Manufacturing. 2023
-
Xueping Yu, Xiupeng Wang, Lue Sun, Atsushi Yamazaki, Xia Li. Tumor microenvironment regulation - enhanced radio - immunotherapy. Biomaterials Advances. 2022. 138. 212867-212867
ｍore...
Patents (4)：
Return to Previous Page
